Search | VHL Search Portal

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Search Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Show: 20 | 50 | 100

Results 1 - 1 de 1

Filter

Phase II clinical trial of one dose of post-transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched-unrelated donor transplantation.

Jamy, Omer; Innis-Shelton, Raquel; Bal, Susan; Paluri, Ravi; Salzman, Donna; Di Stasi, Antonio; Costa, Luciano; Meredith, Ruby; Lamb, Lawrence; Minagawa, Kentaro; Mineishi, Shin; Saad, Ayman.

Am J Hematol ; 96(10): E396-E398, 2021 10 01.

Article in English | MEDLINE | ID: mdl-34288026

Subject(s)

Cyclophosphamide/therapeutic use , Graft vs Host Disease/prevention & control , Immunosuppressive Agents/therapeutic use , Peripheral Blood Stem Cell Transplantation , Cyclophosphamide/administration & dosage , Female , Graft vs Host Disease/etiology , Hematopoietic Stem Cell Transplantation/adverse effects , Humans , Immunosuppressive Agents/administration & dosage , Incidence , Male , Middle Aged , Myeloablative Agonists/therapeutic use , Peripheral Blood Stem Cell Transplantation/adverse effects , Unrelated Donors

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL